Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Amylyx Pharmaceuticals (NASDAQ: AMLX) announced participation in two upcoming virtual investor conferences. Co-CEOs Joshua Cohen and Justin Klee will engage in a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 8:40 am ET, followed by a presentation at the Stifel 2023 CNS Days on March 28, 2023, at 11:00 am ET. Both events will be accessible via live webcast on the company's investor relations page.

Amylyx focuses on developing innovative treatments for neurodegenerative diseases and is headquartered in Cambridge, Massachusetts, with operations in Canada and EMEA.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that Joshua Cohen and Justin Klee, Co-CEOs of Amylyx, will participate in the following upcoming investor conferences, which are being conducted in a virtual format:

• Oppenheimer 33rd Annual Healthcare Conference: Fireside chat on Tuesday, March 14, 2023, at 8:40am ET
• Stifel 2023 CNS Days: Presentation followed by Q&A on Tuesday, March 28, 2023, at 11:00am ET

A live webcast of both conference events can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events, and will be available for replay for 90 days following the events.

About Amylyx Pharmaceuticals

Amylyx Pharmaceuticals, Inc. is committed to supporting and creating more moments for the neurodegenerative disease community through the discovery and development of innovative new treatments. Amylyx is headquartered in Cambridge, Massachusetts and has operations in Canada and EMEA. For more information, visit amylyx.com and follow us on LinkedIn and Twitter. For investors, please visit investors.amylyx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005080/en/

Media

Amylyx Media Team

+1 (857) 799-7274

amylyxmediateam@amylyx.com



Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

+1 (857) 320-6244

Investors@amylyx.com

Source: Amylyx Pharmaceuticals, Inc.

FAQ

What events will Amylyx Pharmaceuticals participate in March 2023?

Amylyx Pharmaceuticals is participating in two virtual investor conferences: a fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on March 14, 2023, at 8:40 am ET, and a presentation at the Stifel 2023 CNS Days on March 28, 2023, at 11:00 am ET.

Where can I watch the Amylyx Pharmaceuticals investor conference presentations?

The investor conference presentations by Amylyx Pharmaceuticals can be watched live via webcast on their investor relations website, with replays available for 90 days post-event.

Who are the Co-CEOs of Amylyx Pharmaceuticals?

The Co-CEOs of Amylyx Pharmaceuticals are Joshua Cohen and Justin Klee.

What is the focus of Amylyx Pharmaceuticals?

Amylyx Pharmaceuticals is committed to the discovery and development of innovative treatments for the neurodegenerative disease community.

What is the stock symbol for Amylyx Pharmaceuticals?

The stock symbol for Amylyx Pharmaceuticals is AMLX.